News

Exciting Keynote Speakers Announced for DPHARM Conference

Exciting Keynote Speakers Announced for DPHARM Conference

Exciting Keynote Speakers Announced for DPHARM Conference

The Conference Forum is thrilled to unveil the first set of keynote speakers for the upcoming DPHARM®: Disruptive Innovations to Modernize Clinical Research conference. This year’s event promises to deliver insights from some of the most influential figures in the healthcare and clinical research fields.

The conference is set to bring together prominent leaders, including former heads of major organizations, to discuss the future of clinical trials and how innovation is reshaping the landscape of patient care. With a growing emphasis on enhancing patient experience and involvement in clinical protocols, this year's keynotes aim to address these critical themes amidst an ever-evolving industry.

The keynotes scheduled for DPHARM 2025 reflect highly respected individuals who come equipped with profound knowledge and experience. According to Tracey Kimball, the DPHARM Conference Director, this year’s selection showcases speakers who have been at the forefront of innovation within the industry.

Notable Keynote Speakers

The impressive lineup includes Kenneth C. Frazier, JD, the retired Chairman and CEO of Merck & Co, Inc. He will present on the importance of integrity in leadership during transformative times and nurturing an environment conducive to innovation.

Scott Gottlieb, MD, the 23rd Commissioner of the US Food and Drug Administration, will share his insights on the future of clinical research, particularly regarding how recent geopolitical shifts might influence research and development efforts.

Furthermore, attendees will hear from Victoria Gray, a Patient Advocate and historical figure as the first recipient of CRISPR gene therapy for sickle cell disease. She will offer a personal perspective on the life-changing impact of participating in clinical trials.

Lastly, Kenneth Getz, MBA, from the Tufts Center for the Study of Drug Development, will tackle the complexities of clinical protocols and how addressing these challenges can alleviate burdens faced by patients and study sites.

Industry Perspectives

Many industry experts recognize the critical juncture the sector faces. Dennis Salotti, Executive Director & Head of Clinical Outsourcing & Innovation at Jazz Pharmaceuticals, echoes this sentiment by emphasizing how current disruptions can serve as catalysts for meaningful innovation and long-term improvements in clinical research.

In addition to the esteemed keynote presentations, DPHARM 2025 will feature more than 200 speakers, all selected with the guidance of a diverse committee representing various sectors, including pharmaceutical executives, regulatory authorities, and patient advocacy groups. This collaborative approach ensures a comprehensive agenda that addresses the multifaceted challenges of modern clinical research.

On the day before the main event, the Partnerships with Sites summit will convene alongside the 10th annual CRAACO®: Clinical Research as a Care Option conference, which will establish a foundation for discussions on collaboration and innovation.

Anyone looking to dive deeper into the DPHARM agenda can find out more about the event’s offerings through the official sources.

About DPHARM

DPHARM®: Disruptive Innovations to Modernize Clinical Research stands out as a unique gathering where thought leaders and senior clinical operations executives present insights into the future of clinical trials. This annual event originated through the collaborative efforts of leading companies in the pharmaceutical sector, including Pfizer and Johnson & Johnson, who remain integral in shaping the program.

Through ongoing engagement and support from industry stakeholders, DPHARM continually seeks to address the evolving needs of clinical trials, particularly from the patient’s perspective, by advocating for more efficient and patient-friendly processes.

About The Conference Forum

The Conference Forum is dedicated to advancing life sciences research through engaging conferences that foster discussions around expediting access to therapeutics for patients. In addition to event facilitation, the firm also produces digital content across various platforms, ensuring widespread dissemination of valuable industry insights.

Frequently Asked Questions

What is DPHARM?

DPHARM is a conference focused on innovations in clinical research, aimed at modernizing trials and improving patient experiences.

Who are some of the keynote speakers for DPHARM 2025?

Keynote speakers include Kenneth C. Frazier, Scott Gottlieb, Victoria Gray, and Kenneth Getz, all recognized leaders in their fields.

When is the DPHARM conference taking place?

DPHARM 2025 is scheduled for September 16-17 at the Loews Philadelphia Hotel.

What topics will be covered at DPHARM 2025?

Topics will include innovations in clinical research, patient advocacy, and the impact of global changes on clinical trials.

Who organizes DPHARM?

DPHARM is organized by The Conference Forum, which specializes in life science conferences focusing on patient access to therapies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 392

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 404

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 291

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 127

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 346

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 181

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 103

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 337

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

IAE International Engine Partnership: Future of Aviation Propulsion

Updated Category News Views 271

IAE International Engine Partnership Reinforces Commitment IAE International Aero Engines (IAE), a collaboration including Japanese Aero Engines Corporation (JAEC), MTU Aero Engines AG (MTU), and Pratt & Whitney, is dedicated to advancing engine technology. Over the years, IAE has been a pillar in the aerospace market, putting forth innovations crucial for commercial...

Continue Reading
Exciting Holiday Attractions Await at Moody Gardens' ICE LAND Exhibit

Updated Category News Views 395

Experience the Magic of the ICE LAND Exhibit at Moody Gardens With the holiday season just around the corner, Moody Gardens is thrilled to announce the opening of its much-anticipated ICE LAND exhibit, themed Pole to Pole. This festive attraction is set to open soon, and it promises to transport visitors on a memorable journey from the icy terrains of the North Pole to...

Continue Reading
PDW Welcomes Dan DeFay as New Vice President of Security

Updated Category News Views 137

PDW Appoints Dan DeFay as Vice President of Information Security PDW has announced the appointment of Dan DeFay as Vice President of Information Security. This is a pivotal role where he will spearhead the company's information security initiatives. Extensive Experience in Cybersecurity Dan DeFay brings over three decades of leadership in cybersecurity and information...

Continue Reading
WITTENSTEIN High Integrity Systems Triumphs with King's Award

Updated Category News Views 192

WITTENSTEIN High Integrity Systems Triumphs with King's Award WITTENSTEIN high integrity systems has achieved a significant milestone by winning the King's Award for Enterprise in the International Trade category. This prestigious honor was officially celebrated with a visit from the Lord-Lieutenant of Somerset, who presented the award at the company’s headquarters in...

Continue Reading
Delta Capital Partners Expands Executive Team for Growth

Updated Category News Views 267

Delta Capital Partners Expands Leadership for Strategic Growth Delta Capital Partners Management, an SEC registered investment adviser specializing in litigation and legal finance, announces exciting changes in its leadership team. The firm welcomes three distinguished professionals: Jason Searfoss as Chief Financial Officer, Elinoar Sofer as Chief Operations Officer, and...

Continue Reading